CVKD
Cadrenal Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.09
−2.68%0
Insider buys (3m)
5
Insider sells (3m)
-$96.2K
Net value (3m)
-64.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 1, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman and CEO | Sale | 7,400 | $3.03 |
| Jun 26, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 9,029 | $3.05 |
| Jun 26, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 2,127 | $3.00 |
| Jun 24, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 9,167 | $3.55 |
| Jun 24, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 2,277 | $3.20 |
| Jun 18, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 513 | $3.16 |
| Jun 18, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 3,613 | $3.18 |
| Jun 15, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 12,996 | $3.94 |
| Jun 15, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 3,666 | $3.58 |
| Jun 15, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 1,462 | $4.12 |
| Jun 10, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 5,893 | $4.38 |
| Jun 10, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 3,500 | $4.21 |
| Jun 10, 2026 | Pham Quang X · director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sale | 12,992 | $4.06 |
| Jun 5, 2026 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 2,323 | $4.26 |
| Jun 5, 2026 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 2,064 | $4.42 |
| Jun 5, 2026 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 3,898 | $4.41 |
| Jun 2, 2026 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 349 | $4.46 |
| Jun 2, 2026 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 303 | $5.01 |
| May 29, 2026 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 6,476 | $5.76 |
| May 29, 2026 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 2,989 | $4.93 |
| May 29, 2026 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 3,298 | $5.28 |
| May 26, 2026 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 1,165 | $5.69 |
| Dec 31, 2025 | Szot Matthew K · officer: Chief Financial Officer | Sale | 9,933 | $6.97 |
| Dec 3, 2025 | Golden Lee Scott · director | A-Award | 5,000 | $8.27 |
| Oct 28, 2025 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 1,315 | $14 |
| Oct 28, 2025 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 1,129 | $14 |
| Oct 28, 2025 | Szot Matthew K · officer: Chief Financial Officer | Sale | 1,800 | $14 |
| Oct 14, 2025 | Pham Quang X · director, 10 percent owner, officer: CEO and Chairman | Sale | 1,800 | $14 |
| Oct 14, 2025 | Szot Matthew K · officer: Chief Financial Officer | Sale | 1,693 | $14 |
| Oct 14, 2025 | Szot Matthew K · officer: Chief Financial Officer | Sale | 1,800 | $14 |
Institutional positioning
13F filings over the trailing two quarters
New 11Increased 6Reduced 6Sold out 6
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 50,137 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 45,201 | May 15, 2026 |
| HRT FINANCIAL LP | New Position | 29,055 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 21,626 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 19,024 | Aug 12, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 8,311 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 8,311 | May 8, 2026 |
| JPMORGAN CHASE & CO | Unchanged | 7,500 | May 13, 2026 |
| BLACKROCK, INC. | Increased | 5,496 | May 13, 2026 |
| Cygnus Capital Advisors, LLC | New Position | 1,492 | May 13, 2026 |
| Tower Research Capital LLC (TRC) | Increased | 1,282 | Aug 11, 2026 |
| UBS Group AG | Increased | 1,112 | Aug 13, 2026 |
| Grove Bank & Trust | New Position | 1,000 | Jul 7, 2026 |
| MORGAN STANLEY | Increased | 706 | Aug 13, 2026 |
| Clearstead Advisors, LLC | New Position | 650 | Aug 6, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 1, 2026